BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11199472)

  • 1. Crosslinked polyvinylalcohol hydrogels as vehicles for hydrophilic drugs.
    Orienti I; Di Pietra A; Luppi B; Zecchi V
    Arch Pharm (Weinheim); 2000 Dec; 333(12):421-4. PubMed ID: 11199472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physically cross-linked chitosan hydrogels as topical vehicles for hydrophilic drugs.
    Cerchiara T; Luppi B; Bigucci F; Orienti I; Zecchi V
    J Pharm Pharmacol; 2002 Nov; 54(11):1453-9. PubMed ID: 12495547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosslinked poly(methyl vinyl ether-co-maleic anhydride) as topical vehicles for hydrophilic and lipophilic drugs.
    Luppi B; Cerchiara T; Bigucci F; Di Pietra AM; Orienti I; Zecchi V
    Drug Deliv; 2003; 10(4):239-44. PubMed ID: 14612339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogels formed by cross-linked polyvinylalcohol as colon-specific drug delivery systems.
    Orienti ; Treré R; Zecchi V
    Drug Dev Ind Pharm; 2001 Sep; 27(8):877-84. PubMed ID: 11699841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel.
    Al-Kassas R; Wen J; Cheng AE; Kim AM; Liu SSM; Yu J
    Carbohydr Polym; 2016 Nov; 153():176-186. PubMed ID: 27561485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of cellulose film containing permeation enhancers for prolonged delivery of propranolol hydrocloride.
    Bigucci F; Abruzzo A; Cerchiara T; Gallucci MC; Luppi B
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1017-25. PubMed ID: 24918172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between novel terpenes and main components of rat and human skin: mechanistic view for transdermal delivery of propranolol hydrochloride.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M; Ali A
    Curr Drug Deliv; 2011 Mar; 8(2):213-24. PubMed ID: 21235472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Formulation and Excipients on Propranolol Skin Permeation and Retention.
    Padula C; Nicoli S; Pescina S; Santi P
    Biomed Res Int; 2018; 2018():1281673. PubMed ID: 30175113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thin polymeric films for the topical delivery of propranolol.
    Padula C; Nicoli S; Pescina S; Santi P
    Colloids Surf B Biointerfaces; 2019 Feb; 174():582-586. PubMed ID: 30502670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Skin Retention and Drug Permeation through Intact and Microneedle Pretreated Skin after Application of Propranolol Loaded Microemulsions.
    Kelchen MN; Brogden NK
    Pharm Res; 2018 Oct; 35(12):228. PubMed ID: 30302631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation, characterization and clinical evaluation of propranolol hydrochloride gel for transdermal treatment of superficial infantile hemangioma.
    Zhou W; He S; Yang Y; Jian D; Chen X; Ding J
    Drug Dev Ind Pharm; 2015; 41(7):1109-19. PubMed ID: 25151873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.
    Gannu R; Vishnu YV; Kishan V; Rao YM
    PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement and mechanism of transdermal absorption of terpene-induced propranolol hydrochloride.
    Cui Y; Li L; Zhang L; Li J; Gu J; Gong H; Guo P; Tong W
    Arch Pharm Res; 2011 Sep; 34(9):1477-85. PubMed ID: 21975809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of a polyvinyl alcohol hydrogen containing phospholipid as controlled-release vehicle for rectal administration of (+/-)-propranolol HCl.
    Morimoto K; Fukanoki S; Hatakeyama Y; Nagayasu A; Morisaka K; Hyon SH; Ikada Y
    J Pharm Pharmacol; 1990 Oct; 42(10):720-2. PubMed ID: 1982145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the in-vitro percutaneous absorption of propranolol from disperse systems.
    Ktistis G; Niopas I
    J Pharm Pharmacol; 1998 Apr; 50(4):413-8. PubMed ID: 9625486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and Evaluation of Cubic Nanoparticles for Improved Transdermal Delivery of Propranolol Hydrochloride.
    Zeng L; Tao C; Liu Z; Zhang J; Zhang M; Zhang J; Fang S; Ma X; Song H; Zhou X
    AAPS PharmSciTech; 2020 Oct; 21(7):266. PubMed ID: 33006694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidyl choline-based colloidal systems for dermal and transdermal drug delivery.
    Ferderber K; Hook S; Rades T
    J Liposome Res; 2009; 19(4):267-77. PubMed ID: 19863162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation study of a patch containing propranolol by design of experiments.
    Cilurzo F; Minghetti P; Gennari CG; Casiraghi A; Selmin F; Montanari L
    Drug Dev Ind Pharm; 2014 Jan; 40(1):17-22. PubMed ID: 23301830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol hydrochloride-loaded liposomal gel for transdermal delivery: Characterization and in vivo evaluation.
    Guan Y; Zuo T; Chang M; Zhang F; Wei T; Shao W; Lin G
    Int J Pharm; 2015 Jun; 487(1-2):135-41. PubMed ID: 25882014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the Dispersion States of Azone in Hydroalcoholic Gels on Its Transdermal Permeation Enhancement Efficacy.
    Chen HL; Cai CC; Ma JY; Yu ML; Zhao MH; Guo JB; Xu H
    J Pharm Sci; 2018 Jul; 107(7):1879-1885. PubMed ID: 29518401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.